Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Recombinant bone morphogenetic protein-2 (rhBMP-2) has pronounced osteoinductive properties, as evidenced by the results of experimental and clinical practices. This applies to both the protein produced in eukaryotic cells and the protein synthesized in bacterial cells. In eukaryotic expression systems, production of the protein is extremely low and, consequently, the cost of materials on its basis is very high. Therefore, optimization of heterologous expression systems for rhBMP-2 production represents an important task. In the present work, optimization of codon composition of the rhBMP-2 gene nucleotide sequence and secondary structure of the transcript, as well as strain selection for efficient gene expression, were carried out. The producing strain based on Escherichia coli BL-21(DE3) provides a high level of rhBMP-2 synthesis (about 57% of total cell proteins). Biological activity of rhBMP-2 dimeric forms purified from the obtained producing strain was measured by induction of alkaline phosphatase activity in C2C12 cells. It is comparable with that of commercial rhBMP-2 expressed in E. coli (R&D Systems, United States). Purified rhBMP-2 does not contain impurities of E. coli endotoxin and can be used in experimental studies of osteoinduction in laboratory animals.

作者简介

A. Karyagina

Gamaleya Federal Research Center for Epidemiology and Microbiology; Belozersky Research Institute of Physico-Chemical Biology; All-Russia Research Institute of Agricultural Biotechnology

编辑信件的主要联系方式.
Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098; Moscow, 119991; Moscow, 127550

I. Boksha

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

T. Grunina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

A. Demidenko

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

M. Poponova

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

O. Sergienko

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098; Moscow, 127550

A. Lyaschuk

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

Z. Galushkina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

L. Soboleva

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

E. Osidak

Gamaleya Federal Research Center for Epidemiology and Microbiology; Imtek Ltd.

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098; Moscow, 121552

A. Semikhin

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

A. Gromov

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098

V. Lunin

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
俄罗斯联邦, Moscow, 123098; Moscow, 127550

补充文件

附件文件
动作
1. JATS XML

版权所有 © Allerton Press, Inc., 2016